These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31852254)

  • 21. Association between novel TARDBP mutations and Chinese patients with amyotrophic lateral sclerosis.
    Xiong HL; Wang JY; Sun YM; Wu JJ; Chen Y; Qiao K; Zheng QJ; Zhao GX; Wu ZY
    BMC Med Genet; 2010 Jan; 11():8. PubMed ID: 20082726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical heterogeneity in Italian patients with amyotrophic lateral sclerosis.
    Piaceri I; Del Mastio M; Tedde A; Bagnoli S; Latorraca S; Massaro F; Paganini M; Corrado A; Sorbi S; Nacmias B
    Clin Genet; 2012 Jul; 82(1):83-7. PubMed ID: 21651514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations.
    Corcia P; Valdmanis P; Millecamps S; Lionnet C; Blasco H; Mouzat K; Daoud H; Belzil V; Morales R; Pageot N; Danel-Brunaud V; Vandenberghe N; Pradat PF; Couratier P; Salachas F; Lumbroso S; Rouleau GA; Meininger V; Camu W
    Neurology; 2012 May; 78(19):1519-26. PubMed ID: 22539580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional complementation in Drosophila to predict the pathogenicity of TARDBP variants: evidence for a loss-of-function mechanism.
    Vanden Broeck L; Kleinberger G; Chapuis J; Gistelinck M; Amouyel P; Van Broeckhoven C; Lambert JC; Callaerts P; Dermaut B
    Neurobiol Aging; 2015 Feb; 36(2):1121-9. PubMed ID: 25442115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial ALS with G298S mutation in TARDBP: a comparison of CSF tau protein levels with those in sporadic ALS.
    Nozaki I; Arai M; Takahashi K; Hamaguchi T; Yoshikawa H; Muroishi T; Noguchi-Shinohara M; Ito H; Itokawa M; Akiyama H; Kawata A; Yamada M
    Intern Med; 2010; 49(12):1209-12. PubMed ID: 20558945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease.
    Lattante S; Conte A; Zollino M; Luigetti M; Del Grande A; Marangi G; Romano A; Marcaccio A; Meleo E; Bisogni G; Rossini PM; Sabatelli M
    Neurology; 2012 Jul; 79(1):66-72. PubMed ID: 22722621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants.
    Bertolin C; D'Ascenzo C; Querin G; Gaiani A; Boaretto F; Salvoro C; Vazza G; Angelini C; Cagnin A; Pegoraro E; Sorarù G; Mostacciuolo ML
    Neurobiol Aging; 2014 May; 35(5):1212.e7-1212.e10. PubMed ID: 24325798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis.
    Goutman SA; Chen KS; Paez-Colasante X; Feldman EL
    Handb Clin Neurol; 2018; 148():603-623. PubMed ID: 29478603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant TDP-43 Causes Early-Stage Dose-Dependent Motor Neuron Degeneration in a TARDBP Knockin Mouse Model of ALS.
    Ebstein SY; Yagudayeva I; Shneider NA
    Cell Rep; 2019 Jan; 26(2):364-373.e4. PubMed ID: 30625319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare homozygosity in amyotrophic lateral sclerosis suggests the contribution of recessive variants to disease genetics.
    Goldstein O; Kedmi M; Gana-Weisz M; Twito S; Nefussy B; Vainer B; Fainmesser Y; Abraham A; Nayshool O; Orr-Urtreger A; Drory VE
    J Neurol Sci; 2019 Jul; 402():62-68. PubMed ID: 31108397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease.
    Synofzik M; Born C; Rominger A; Lummel N; Schöls L; Biskup S; Schüle C; Grasshoff U; Klopstock T; Adamczyk C
    Neurobiol Aging; 2014 May; 35(5):1212.e1-5. PubMed ID: 24300238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
    Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
    J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enlarging clinical spectrum of FALS with TARDBP gene mutations: S393L variant in an Italian family showing phenotypic variability and relevance for genetic counselling.
    Origone P; Caponnetto C; Bandettini Di Poggio M; Ghiglione E; Bellone E; Ferrandes G; Mancardi GL; Mandich P
    Amyotroph Lateral Scler; 2010; 11(1-2):223-7. PubMed ID: 19714537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of the mutation spectrum in 301 German ALS families.
    Müller K; Brenner D; Weydt P; Meyer T; Grehl T; Petri S; Grosskreutz J; Schuster J; Volk AE; Borck G; Kubisch C; Klopstock T; Zeller D; Jablonka S; Sendtner M; Klebe S; Knehr A; Günther K; Weis J; Claeys KG; Schrank B; Sperfeld AD; Hübers A; Otto M; Dorst J; Meitinger T; Strom TM; Andersen PM; Ludolph AC; Weishaupt JH;
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):817-827. PubMed ID: 29650794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for TARDBP mutations in Japanese familial amyotrophic lateral sclerosis.
    Kamada M; Maruyama H; Tanaka E; Morino H; Wate R; Ito H; Kusaka H; Kawano Y; Miki T; Nodera H; Izumi Y; Kaji R; Kawakami H
    J Neurol Sci; 2009 Sep; 284(1-2):69-71. PubMed ID: 19411082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDBP mutation.
    Fujita Y; Ikeda M; Yanagisawa T; Senoo Y; Okamoto K
    Neurology; 2011 Oct; 77(15):1427-31. PubMed ID: 21956716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.
    Kabashi E; Valdmanis PN; Dion P; Spiegelman D; McConkey BJ; Vande Velde C; Bouchard JP; Lacomblez L; Pochigaeva K; Salachas F; Pradat PF; Camu W; Meininger V; Dupre N; Rouleau GA
    Nat Genet; 2008 May; 40(5):572-4. PubMed ID: 18372902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
    Barmada SJ; Finkbeiner S
    Rev Neurosci; 2010; 21(4):251-72. PubMed ID: 21086759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TARDBP in amyotrophic lateral sclerosis: identification of a novel variant but absence of copy number variation.
    Bäumer D; Parkinson N; Talbot K
    J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1283-5. PubMed ID: 19864663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS.
    Tsai CP; Soong BW; Lin KP; Tu PH; Lin JL; Lee YC
    Neurobiol Aging; 2011 Mar; 32(3):553.e13-21. PubMed ID: 20472325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.